120 related articles for article (PubMed ID: 37097679)
21. [Complete disappearance of pulmonary metastases in a case of rectal cancer treated with oral tegafur-uracil (UFT) and leucovorin (LV)].
Takada A; Kawahara M; Kobayashi H; Takino Y; Kodama T; Sugishita T; Ohno Y; Oka T; Tsukamoto F
Gan To Kagaku Ryoho; 2012 Jun; 39(6):997-9. PubMed ID: 22705701
[TBL] [Abstract][Full Text] [Related]
22. Benefit of tegafur-uracil and leucovorin in chemoradiotherapy for rectal cancer.
Ishihara S; Hayama T; Yamada H; Nozawa K; Matsuda K; Watanabe T
Hepatogastroenterology; 2011; 58(107-108):756-62. PubMed ID: 21830385
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
[TBL] [Abstract][Full Text] [Related]
24. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.
Hoff PM; Janjan N; Saad ED; Skibber J; Crane C; Lassere Y; Cleary KR; Benner S; Randolph J; Abbruzzese JL; Pazdur R
J Clin Oncol; 2000 Oct; 18(20):3529-34. PubMed ID: 11032595
[TBL] [Abstract][Full Text] [Related]
25. Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer.
Yang TS; Wang JY; Tang R; Hsu KC; Chen JS
Jpn J Clin Oncol; 2002 Sep; 32(9):352-7. PubMed ID: 12417601
[TBL] [Abstract][Full Text] [Related]
26. Randomized phase II study of tegafur-uracil/leucovorin versus tegafur-uracil/leucovorin plus oxaliplatin after curative resection of high-risk stage II/III colorectal cancer (SOAC-1101 trial).
Kosugi C; Koda K; Takiguchi N; Takaishi S; Miyauchi H; Hirayama N; Nomura Y; Kondo E; Kawasaki Y; Ozawa Y; Matsubara H
Int J Colorectal Dis; 2021 Aug; 36(8):1739-1749. PubMed ID: 33715077
[TBL] [Abstract][Full Text] [Related]
27. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
28. The benefit of post-operative adjuvant chemotherapy using oral fluoropyrimidines in rectal cancer.
Ogata Y; Matono K; Torigoe S; Mizobe T; Sasatomi T; Ishibashi N; Shida S; Ohkita A; Fukumitu T; Ikeda S; Ogo S; Ozasa H; Shirouzu K
Kurume Med J; 2005; 52(1-2):1-7. PubMed ID: 16119607
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience.
Yen HH; Chen CN; Yeh CC; Lai IR
World J Surg Oncol; 2021 Apr; 19(1):124. PubMed ID: 33865416
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant Chemotherapy With UFT/LV
Ogawa H; Shiraishi T; Okada T; Miyamae Y; Motegi Y; Shirabe K; Saeki H
Anticancer Res; 2024 Feb; 44(2):805-814. PubMed ID: 38307591
[TBL] [Abstract][Full Text] [Related]
31. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
32. [Two cases of recurrent colorectal cancer treated successfully with folinate/tegafur/uracil (UFT/LV) chemotherapy on an outpatient basis].
Hosotaki K; Tabira Y; Shimamoto M; Tamori Y
Gan To Kagaku Ryoho; 2008 Apr; 35(4):661-4. PubMed ID: 18408440
[TBL] [Abstract][Full Text] [Related]
33. Cost minimization comparison of oral UFT/leucovorin versus 5-fluorouracil/leucovorin as adjuvant therapy for colorectal cancer in Taiwan.
Hsu TC; Wang CC
J Comp Eff Res; 2019 Jan; 8(2):73-79. PubMed ID: 30560687
[TBL] [Abstract][Full Text] [Related]
34. Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502.
Sadahiro S; Tsuchiya T; Sasaki K; Kondo K; Katsumata K; Nishimura G; Kakeji Y; Baba H; Sato S; Koda K; Yamaguchi Y; Morita T; Matsuoka J; Usuki H; Hamada C; Kodaira S
Ann Oncol; 2015 Nov; 26(11):2274-80. PubMed ID: 26347106
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
[TBL] [Abstract][Full Text] [Related]
36. [A Curatively Resected Case of Lateral Lymph Node Metastasis Five-Years after Initial Surgery for Rectal Cancer].
Miura T; Tsunenari T; Sasaki T; Yokoyama T; Fukuhara K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1405-1407. PubMed ID: 29394649
[TBL] [Abstract][Full Text] [Related]
37. Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer.
Chen TC; Jeng YM; Liang JT
J Formos Med Assoc; 2021 May; 120(5):1194-1201. PubMed ID: 33023787
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant therapy with protein-bound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial.
Ohwada S; Kawate S; Ikeya T; Yokomori T; Kusaba T; Roppongi T; Takahashi T; Nakamura S; Kawashima Y; Nakajima T; Morishita Y;
Dis Colon Rectum; 2003 Aug; 46(8):1060-8. PubMed ID: 12907900
[TBL] [Abstract][Full Text] [Related]
39. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N
J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer.
Schiebe ME; Reese T; Wenz F; Schmidberger H; Engenhart-Cabillic R; Dunst J; Hess CF; Hoffmann W
Anticancer Drugs; 2002 Nov; 13(10):1005-9. PubMed ID: 12439334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]